These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23419873)

  • 1. Carbonyl reduction of triadimefon by human and rodent 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Da Cunha T; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Biochem Pharmacol; 2013 May; 85(9):1370-8. PubMed ID: 23419873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Drug Metab Dispos; 2013 Sep; 41(9):1671-8. PubMed ID: 23804523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
    Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
    Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid.
    Penno CA; Morgan SA; Vuorinen A; Schuster D; Lavery GG; Odermatt A
    J Lipid Res; 2013 Oct; 54(10):2874-83. PubMed ID: 23933573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
    Hintzpeter J; Stapelfeld C; Loerz C; Martin HJ; Maser E
    PLoS One; 2014; 9(1):e84468. PubMed ID: 24404164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
    Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.
    Hult M; Elleby B; Shafqat N; Svensson S; Rane A; Jörnvall H; Abrahmsen L; Oppermann U
    Cell Mol Life Sci; 2004 Apr; 61(7-8):992-9. PubMed ID: 15095019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic investigation of the noncytochrome P450-mediated metabolism of triadimefon to triadimenol in hepatic microsomes.
    Kenneke JF; Mazur CS; Ritger SE; Sack TJ
    Chem Res Toxicol; 2008 Oct; 21(10):1997-2004. PubMed ID: 18763812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats.
    Hu GX; Lin H; Lian QQ; Zhou SH; Guo J; Zhou HY; Chu Y; Ge RS
    PLoS One; 2013; 8(3):e49976. PubMed ID: 23533564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
    Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
    PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11β-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice.
    Coutinho AE; Gray M; Brownstein DG; Salter DM; Sawatzky DA; Clay S; Gilmour JS; Seckl JR; Savill JS; Chapman KE
    Endocrinology; 2012 Jan; 153(1):234-40. PubMed ID: 22067318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N; Kubota S; Kobayashi Y; Kato I
    Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
    Johansson L; Fotsch C; Bartberger MD; Castro VM; Chen M; Emery M; Gustafsson S; Hale C; Hickman D; Homan E; Jordan SR; Komorowski R; Li A; McRae K; Moniz G; Matsumoto G; Orihuela C; Palm G; Veniant M; Wang M; Williams M; Zhang J
    J Med Chem; 2008 May; 51(10):2933-43. PubMed ID: 18419108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.